Why PTC Histological Biopsy Needle Becomes The Gold Standard For Cervical Pathological Diagnosis

Oct 12, 2026

 

1. Industry Pain Points of Traditional Cervical Diagnostic Technology

The traditional cervical lesion diagnosis system has obvious technical loopholes, which restrict the accuracy and authority of clinical diagnosis. First, CTC cytological screening is only a superficial screening means, which can only judge abnormal cell morphology, but cannot confirm the depth and scope of lesion infiltration, and has a high false positive and false negative rate. For patients with atypical squamous cells and ambiguous erosion lesions, CTC cannot provide definite diagnostic conclusions, resulting in clinical diagnostic ambiguity. Second, traditional biopsy needles have rough process and single specification, unable to adapt to individualized lesion characteristics of different patients. Too thick needles cause excessive tissue damage, while too thin needles lead to insufficient sampling, both affecting the accuracy of pathological results. Third, the surface of traditional equipment is easy to adhere to tissues and bacteria, which increases the risk of specimen contamination and postoperative infection, and cannot meet the high sterile requirements of pathological examination. Fourth, the traditional diagnostic process is fragmented, with disjointed colposcopy observation, CTC screening and biopsy sampling, resulting in long diagnostic cycle, low efficiency and serious waste of medical resources. For a long time, the lack of high-precision, standardized and integrated biopsy equipment has made it difficult for cervical pathological diagnosis to form a unified gold standard, affecting the standardized development of gynecological oncology diagnosis and treatment.

2. Core Working Principle of PTC Biopsy Needle Supporting Gold Standard Diagnosis

The core reason why PTC histological biopsy needle can become the gold standard for cervical pathological diagnosis lies in its precise, stable and complete tissue sampling principle. Different from cytological screening which only collects superficial cells, PTC biopsy needle realizes deep tissue in-situ sampling through percutaneous minimally invasive puncture technology. The medical stainless steel needle body has ultra-high hardness and toughness, which can stably penetrate cervical epithelial tissue and reach the lesion basal layer. The built-in precision sampling groove and synchronous cutting structure can completely intercept the lesion tissue with complete cell arrangement and tissue structure, which is the key to support authoritative histological diagnosis. After multi-process surface treatment such as polishing, electroplating and ultrasonic cleaning, the needle body achieves zero bacterial residue and ultra-low tissue adhesion, ensuring the purity and integrity of pathological specimens and avoiding diagnostic errors caused by specimen contamination or damage. The adjustable diameter design covers all types of cervical lesions from micro to large area, realizing individualized precise sampling. Combined with 40-fold colposcopy visual positioning, it realizes the integration of lesion observation, precise positioning and standardized sampling, forming a closed-loop diagnostic principle of "visual screening - precise sampling - histological confirmation".

3. Product Classification and Gold Standard Adaptability Analysis

PTC histological biopsy needles form a complete product matrix covering all cervical diagnostic scenarios, matching the gold standard requirements of different diagnostic levels. First, primary screening type (0.25mm–5mm), suitable for population general screening and CTC preliminary abnormal recheck. It features fast sampling and minimal trauma, which can quickly screen high-risk lesion groups and lay a foundation for primary diagnosis. Second, definitive diagnostic type (5mm–20mm), the core model of gold standard diagnosis, suitable for all suspected cervical cancer lesions and atypical erosion lesions. It can obtain sufficient and complete lesion tissues, support accurate judgment of benign and malignant lesions, lesion staging and infiltration degree, and is the most authoritative sampling equipment for clinical definitive diagnosis. Third, customized special type (20mm–30mm), aiming at complex recurrent lesions and large-area cervical lesions, realizing full coverage sampling of lesion tissues, avoiding missed sampling of marginal lesions, and ensuring the comprehensiveness of diagnosis. In terms of process classification, the sterile enhanced model passes strict ISO 9001 quality certification, with stable product batch consistency, ensuring uniform sampling standards in different medical environments, which is an important guarantee for unifying industry diagnostic gold standards.

4. Standard Sampling Operation Guidelines for Definitive Diagnosis

To ensure that the sampling results meet the gold standard of pathological diagnosis, the operation of PTC histological biopsy needle must implement strict standardized procedures. First, preoperative lesion grading: grade cervical erosion and abnormal lesions through colposcopy 40-fold magnification observation, clarify lesion size, depth and distribution, and select the most appropriate needle diameter specification. Second, sterile standardized preparation: disinfect the operating area and equipment strictly in accordance with medical sterile specifications, check the needle body sharpness and cutting function to ensure no equipment failure during operation. Third, precise positioning and sampling: select the most typical lesion site as the sampling point under colposcopy monitoring, puncture vertically at a constant speed, control the puncture depth accurately, start the cutting device to obtain tissue samples, and ensure that the sampled tissue contains lesion epithelial and basal layer structures. Fourth, specimen standardized processing: place the sampled tissue in special fixing solution immediately, label detailed patient information and sampling site, and send it to the pathology department for professional histological sectioning, staining and microscopic examination. Fifth, diagnostic result verification: combine CTC screening results, colposcopy imaging data and biopsy pathological results for comprehensive judgment to form a definitive diagnostic conclusion.

5. Industry Influence and Practical Recognition

At present, PTC histological biopsy needle has been widely recognized as the core equipment of cervical pathological diagnosis gold standard in the industry, completely changing the dilemma of ambiguous and inconsistent traditional diagnosis. Its complete tissue sampling capability solves the fundamental problem that cytological screening cannot make a definitive diagnosis, and provides accurate and reliable specimen support for clinical pathological diagnosis. The standardized product specifications and unified operation standards unify the diagnostic criteria of different medical institutions, effectively reducing the misdiagnosis rate and missed diagnosis rate of cervical lesions. The minimally invasive and high-safety performance greatly improves the safety of clinical diagnosis, reduces medical disputes caused by diagnostic errors and surgical complications. In the global medical industry, with the popularization of cervical cancer early screening projects, PTC biopsy needles, as high-quality and standardized histological sampling equipment, have been widely applied in various countries and regions, promoting the unified and standardized development of global cervical lesion diagnosis standards, and making important contributions to improving the early diagnosis rate and cure rate of cervical cancer.